CosBeauty

CosBeauty, founded in 2013, is a pioneering player in the Consumer Goods industry, offering precision in skin health with scientifically-backed, professional solutions. With a commitment to scientific research and development, the company has garnered a strong consumer base of over 2 million across regions including China, Europe, America, Asia Pacific, and the Middle East.

At the center of CosBeauty's operations lies the Institute of Precision Medicine, which integrates experts in biomedicine, bioinformatics, medical engineering, optoelectronics, and artificial intelligence. This collaborative effort has resulted in a robust R&D system leveraging life sciences, applied physics, big data, and AI, projecting the company as a key player in the home-use medical-grade skincare market.

Noteworthy is the CNY20.00M Series B investment secured on 05 June 2017, demonstrating strong investor confidence. The investment was led by significant names such as ZSVC, Shenzhen Capital Group, 前海恒昇(深圳)基金管理有限公司, Fortune Link, NewMargin Ventures, QC Investment, and Sangel Capital, highlighting CosBeauty's appeal to a diverse range of investment entities.

With its innovative approach towards skincare backed by substantial investor support, CosBeauty is poised for a glowing future on the global stage.